LY96 encodes MD2, an accessory molecule required for the activation of toll-like receptor-4, which promotes cell survival and induces the secretion of immunosuppressive molecules that promote tumor evasion from immune surveillance [30]. The gene discussed is TLR4; the disease is neoplasm.